Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Aequus Pharmaceuticals logo — Advancing Canadian healthcare through licensing and partners...

Aequus Pharmaceuticals

Advancing Canadian healthcare through licensing and partnerships

Founded 2013 Canada Canada 8 employees Post-IPO Debt Health Care, Pharmaceutical

General Information

Company Name Aequus Pharmaceuticals
Founded Year 2013
Location Canada Canada
Employees 8
Industries Health Care, Pharmaceutical
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Aequus Pharmaceuticals. To contact Aequus Pharmaceuticals, visit aequuspharma.ca.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aequus Pharmaceuticals compare?

A PDF of Aequus Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aequus Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aequus Pharmaceuticals

Aequus Pharmaceuticals is a Canadian specialty pharmaceutical company committed to advancing Canadian healthcare through licensing and partnerships. With a focus on developing and commercializing high-quality, differentiated products, the company's sales and marketing efforts are directed towards highly specialized therapeutic areas within Canada. Aequus continues to expand its pipeline through new partnerships and has recently augmented its portfolio with several commercial-stage products through in-licensing and distribution agreements. The company's commercial programs are underpinned by insights from patients, physicians, and payers. Aequus' management team possesses a proven track record in successfully navigating clinical development, regulatory approvals, and product marketing. The company is actively leveraging its internal capabilities and knowledge to execute an efficient commercial strategy and development plan aimed at driving shareholder value. Aequus is particularly focused on therapeutic areas such as neurology, ophthalmology, and transplant. Moreover, it is developing a pipeline of products in neurology and psychiatry to address the need for enhanced medication adherence through improved delivery systems. Established in 2013, Aequus Pharmaceuticals operates within the Health Care and Pharmaceutical industries. Its recent financial activity includes a Post-IPO Debt investment on 06 July 2023. Notably, no specific information is provided regarding the investors involved in this latest investment.

Business keywords: pharmaceuticals, commercialization, specialized therapeutic areas, medication adherence, neurology, ophthalmology, transplant, partnerships, licensing agreements, marketing strategy, clinical development, regulatory approval, patient insights, physician collaboration

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt Undisclosed -
06 Jul 2023
Post IPO Equity Undisclosed -
06 Aug 2020
Post IPO Debt Undisclosed -
26 Apr 2019
Post IPO Equity Undisclosed -
31 Jan 2018
Post IPO Equity Undisclosed -
13 Mar 2017
Post IPO Equity Undisclosed -
25 Jan 2016
Funding Round Undisclosed -
20 Nov 2014
Series A Undisclosed -
26 Sep 2013

Aequus Pharmaceuticals Alternatives & Competitors

View All Alternatives
Aequus Pharmaceuticals vs
Avillion Life Sciences
Avillion Life Sciences United Kingdom

Accelerating global drug development through successful partnering for patient benefit

Venture round
25 employees
Health Care, Health and Wellness
Aequus Pharmaceuticals vs
Asieris Pharmaceuticals
Asieris Pharmaceuticals United States

We strive for healthy and dignified lives!

Series D
60 employees
Biotechnology, Health Care
Aequus Pharmaceuticals vs
ZYUS Life Sciences
ZYUS Life Sciences Canada

Advancing the Science of Well-Being.

Post-IPO Debt
53 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Aequus Pharmaceuticals

Advancing Canadian healthcare through licensing and partnerships
Aequus Pharmaceuticals was founded in 2013.
Aequus Pharmaceuticals is headquartered in Canada.
Aequus Pharmaceuticals operates in Health Care and Pharmaceutical. Its work centres on pharmaceuticals, commercialization, specialized therapeutic areas and medication adherence.
Aequus Pharmaceuticals has approximately 8 employees.
Aequus Pharmaceuticals has completed 8 funding rounds. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Aequus Pharmaceuticals include Avillion Life Sciences, Asieris Pharmaceuticals, ZYUS Life Sciences, SFJ Pharmaceuticals, Inc., AMW GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aequus Pharmaceuticals and Avillion Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aequus Pharmaceuticals, https://bouncewatch.com/company/aequus-pharmaceuticals, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout